主講者

大會演講者

David   T.W.   Wong ,  D.M.D., D.M.SC.

Professor

Director of the UCLA Center for Oral/Head & Neck Oncology Research (COOR)


David T.W. Wong, D.M.D., D.M.Sc., is a professor in the Section of Biosystems and Function in the Division of Oral and Systemic Health Sciences. He is the director of the UCLA Center for Oral/Head and Neck Oncology Research. An active scientist in oral cancer and saliva diagnostics research. He has authored over 320 peer-reviewed scientific publications. He is a fellow of the American Association for the Advancement of Sciences (AAAS), past member of the ADA Council of Scientific Affairs and the past president of American Association of Dental Research (AADR). Dr. Wong's Lab website (https://www.hspp.ucla.edu).


大會演講者

莊曜宇教授   Eric Y. Chuang, Ph. D. (Taiwan, ROC)

工業技術研究院副總兼生醫與醫材研究所所長

臺灣大學生醫電子與資訊學研究所教授


Dr Chuang obtained his PhD in cancer biology, specializing in toxicology and molecular genetics from Harvard University in 1997, focusing on radiation-induced mutagenesis in human cells for his doctoral thesis. He then joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as an IRTA fellow, researching radiogenomics, and later became Head of the Microarray Laboratory for Radiation Oncology Sciences Program at NCI, where he advanced microarray technologies for studying radiation-induced molecular mechanisms and genomic effects.

In 2011, he returned to National Taiwan University (NTU), serving as Director of the Graduate Institute of Biomedical Electronics and Bioinformatics (BEBI) from 2012 to 2018, and held an EMBA from NTU. Currently, he’s a BEBI Professor and General Director of Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute (ITRI), Hsinchu, Taiwan, being an expert in Genomic Technologies, Bioinformatics, Cancer, Oncology, Radiation Biology, Biomedical Engineering, and Precision Medicine. He has authored over 165 peer-reviewed publications, and also serves on the editorial board of Scientific Reports and is Editor-in-Chief of Translational Cancer Research.